[KAIST GSMSE Jeongho Lee]

2018년 8월 8일 업데이트됨

첨부문서 : Lab_pre IR_JH Lee.pdf

[Project Leader : Jeong-Ho Lee Organization : KAIST]


Research Sector

1. Human Genetics

2. Neuroscience

3. Disease-Modeling

4. Discovery of drug target & Drug-repositioning

 Research Goal

1.Discovery of new therapeutic target for FCD related epilepsy in patients

2.Generation of model mouse with identified mutation

3.Targeted therapy

Therapeutic Area

Drug-resistant Epilepsy

 Stage of Research

Phase III Clinical trial for the drug-repositioning of the previously FDA-approved mTOR inhibitor as a cancer drug by a global pharmaceutical company.

  • Facebook Social Icon

상호 : CHIP KAIST  |  대표 : 신성철
사업자 등록번호 : 314-82-01980  |  개인정보관리책임자 : CHIP KAIST
KAIST 371-1 Guseong-dong, Yuseong-gu, Daejeon, South Korea
PHONE : 042-350-4951 | EMAIL : chipkaist2016@gmail.com